Jindal N, Lad DP, Malhotra P, Prakash G, et al. Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLL. Leuk Lymphoma 2021;62:1674-1681.
PMID: 33612059